| Janssen-Cilag AG - DARZALEX SC 1800 mg/15 ml, Injektionslösung | | 67689 | | 01 | | DARZALEX SC 1800 mg/15 ml | | Injektionslösung | | L01FC01 | | | | 13.08.2020 | | |
| | Composition | | daratumumabum 1800 mg, hyaluronidasum humanum ADNr, histidinum, histidini hydrochloridum monohydricum, sorbitolum 735.1 mg, methioninum, polysorbatum 20, aqua ad iniectabile ad solutionem pro 15 ml. | | Packungsbestandteile | | Injection solution | | | | | | | | Active Agent | Dose |
|---|
| Daratumumabum | 1800mg / 15ml |
| | BAG: Active Agent | Dose |
|---|
| Daratumumabum | 1800 mg |
| | | | Inactive agents | Dose |
|---|
| Histidin Hydrochloride Monohydrate | | | Histidine | | | Hyaluronidasum Humanum Adnr | | | Methionine | | | Polysorbatum 20 | | | Sorbitol | 735.1mg / 15ml |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | | 4788.48 | 5220.80 | A | SL | Yes |
|
|
